EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview

Danish Sultan, Bianca J J M Brundel iD, Kondababu Kurakula iD

Cells · 04.06.2025 · 14 (11) · 839

DOI: 10.3390/cells14110839 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.06.2025. Verfasst von Danish Sultan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Pulmonary Hypertension…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hypertension, Pulmonary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NWO, NWA-ORC project CIRCULAR NWO, ERC (European Research Council).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH) is a progressive lung disease characterized by abnormal pulmonary vascular pressure and right ventricular (RV) dysfunction. Atrial arrhythmias, including atrial fibrillation (AF) and atrial flutter, are common in patients with PH and significantly contribute to disease progression and mortality. A bidirectional pathophysiological link exists between PH and AF, encompassing shared mechanisms such as endothelial dysfunction, DNA damage, autophagy, inflammation, and oxidative stress, as well as mutual risk factors, including diabetes, obesity, heart disease, and aging. Despite these shared pathways, limited research has been conducted to fully understand the intertwined relationship between PH and AF, hindering the development of effective treatments. In this review, we provide a comprehensive overview of the epidemiology of PH, the molecular mechanisms underlying the development of AF in PH, and the overlap in their pathophysiology. We also identify novel druggable targets and propose mechanism-based therapeutic approaches to treat this specific patient group. By shedding light on the molecular connection between PH and AF, this review aims to fuel the design and validation of innovative treatments to address this challenging comorbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHypertension, PulmonaryHumansAnimalsOxidative StressRisk Factors

Stichwörter der Autor:innen

DNA damageatrial fibrillationautophagyproteostasispulmonary hypertension

Autor:innen und Institutionen

  • Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Pulmonary Hypertension and Thrombosis, 1081 HZ Amsterdam, The Netherlands.

ORCID-Profile: Bianca J J M Brundel, Kondababu Kurakula

Förderung

  • NWO
  • NWA-ORC project CIRCULAR NWO
  • ERC (European Research Council)
  • Amsterdam University Medical Center

Zitieren

APA

Sultan, D., Brundel, B. J. J. M., & Kurakula, K. (2025). The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview. Cells, 14(11), 839. https://doi.org/10.3390/cells14110839

Vancouver

Sultan D, Brundel BJJM, Kurakula K. The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview. Cells. 2025;14(11):839. doi:10.3390/cells14110839

BibTeX
@article{Sultan2025,
  author = {Sultan, Danish and Brundel, Bianca J J M and Kurakula, Kondababu},
  title = {The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {11},
  pages = {839},
  doi = {10.3390/cells14110839}
}
Kostenlos starten →